CFSAN/CDRH Study Examines Potential Skin Damage From Hydroxy Acids
This article was originally published in The Rose Sheet
Executive Summary
FDA's Center for Devices & Radiological Health and Center for Food Safety & Applied Nutrition are evaluating use of certain alpha hydroxy and beta hydroxy acids in cosmetics to determine if the ingredients may increase the risk of skin cancer, CDRH Senior Research Biophysicist Janusz Beer, MD, said during a presentation at the 2004 FDA Science Forum in Washington, D.C. May 18-19
You may also be interested in...
CFSAN Cosmetics Oversight Aided By NTP, CDER Collaboration
FDA's Center for Food Safety & Applied Nutrition is tapping the expertise of other agencies and centers within the Department of Health & Human Services to monitor emerging technologies related to cosmetics
CFSAN Cosmetics Oversight Aided By NTP, CDER Collaboration
FDA's Center for Food Safety & Applied Nutrition is tapping the expertise of other agencies and centers within the Department of Health & Human Services to monitor emerging technologies related to cosmetics
Are Wrinkle Treatments With AHAs, BHAs OTCs? FDA Issues Call For Data
FDA is requesting information on the possible physiological effects of alpha hydroxy and beta hydroxy acids in wrinkle removers to help evaluate their regulatory status, according to a Dec. 31 Federal Register notice